N/A
N=146
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
Scar · Skin Scarring · Skin Cancer · Wound Heal · Wound of Skin
Bottom Line
View on ClinicalTrials.gov: NCT05618912 ↗Enrolled (actual)
146
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Cosmetic Outcome — 7.4; 6.6; 6.3; 6.00 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Hydrocolloid dressing (Device); Petrolatum jelly dressing (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Indiana University
- Primary completion
- Oct 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cosmetic Outcome |
8.2; 8.1; 7.94; 7.92; 7.1; 6.6 | — |
| PRIMARY Cosmetic Outcome |
8.2; 8.1; 7.94; 7.92; 7.1; 6.6 | — |
| PRIMARY Cosmetic Outcome |
8.2; 8.1; 7.94; 7.92; 7.1; 6.6 | — |
| SECONDARY Number of Participants With Complications |
29; 28; 14; 7; 0; 0 | — |
Summary
Patients will be randomized either to receive standard daily dressing or hydrocolloid dressing using a randomization generator. After closing the wound with the sutures,the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days(Experimental) or the standard dressing (Control) that will be covered with petrolatum jelly and bandaging during this time period, which has to be re-applied daily. Patients and dermatologic surgeons will then complete surveys 7 days, 30 days, and 90 days after surgery to evaluate the cosmetic appearance of these scars.
Eligibility Criteria
Inclusion Criteria
- Adult > 18 years of age
- Linear scars
- Patients underwent conventional excision or Mohs micrographic surgery for primary cutaneous cancer or other cutaneous condition that required surgical intervention
Exclusion Criteria
- Scar localization on acral or hair bearing sites
- Patients unable to converse in English
- Patients requiring flap or graft for closure of wound
- History of allergy to adhesives
- Patient using topical chemotherapy agents on the surgical site or planning to start it within 3 months after surgery
- Use of hydrocolloid dressings for post-operative wound care in the past
Data sourced from ClinicalTrials.gov (NCT05618912). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.